Status:

RECRUITING

Selective Removal of Endometriotic Lesions Using CUSA Clarity in Ovarian Endometriomas

Lead Sponsor:

Kanazawa University

Conditions:

Ovarian Endometrioma

Endometriosis

Eligibility:

FEMALE

20+ years

Brief Summary

This study aims to evaluate the feasibility and tissue selectivity of a novel surgical technology, the Cavitron Ultrasonic Surgical Aspirator (CUSA) Clarity, in the management of ovarian endometriomas...

Detailed Description

Endometriomas are one of the most common manifestations of endometriosis and are frequently associated with infertility. Conventional cystectomy often results in inadvertent removal of normal ovarian ...

Eligibility Criteria

Inclusion

  • Female patients diagnosed with ovarian endometrioma who undergo surgical treatment (cystectomy or adnexectomy) at Kanazawa University Hospital between January 1, 2025, and March 31, 2027.
  • Written informed consent obtained prior to study participation.
  • Age ≥ 20 years at the time of consent.
  • For patients with previously stored endometrioma specimens under a broad consent, additional written consent for participation in this study will be obtained.

Exclusion

  • Patients with suspected malignancy based on preoperative imaging.
  • Patients judged by the attending physician to be unsuitable for participation in this study for any reason.

Key Trial Info

Start Date :

January 30 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 31 2028

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT07215130

Start Date

January 30 2025

End Date

March 31 2028

Last Update

October 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kanazawa University Hospital

Kanazawa, Ishikawa-ken, Japan, 9208641